UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Radiotherapy in head and neck cancer management: United Kingdom National Multidisciplinary Guidelines

Journal of laryngology and otology, 2016-05, Vol.130 (S2), p.S66-S67

Nutting, C

2016

Volltextzugriff (PDF)

Rapid advances in auto-segmentation of organs at risk and target volumes in head and neck cancer

Radiotherapy and oncology, 2019-06, Vol.135, p.130-140

2019

Volltextzugriff (PDF)

SP-0533: Combined modality treatment: risk-adapted intensified strategies and quality of life

Radiotherapy and oncology, 2015-04, Vol.115, p.S258-S258

Nutting, C

2015

Volltextzugriff (PDF)

Head and neck cancer--Part 1: Epidemiology, presentation, and prevention

BMJ, 2010-09, Vol.341 (7774), p.c4684-c4684

International edition, 2010

Volltextzugriff (PDF)

Transformation to “high grade” neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinoma

Lung cancer (Amsterdam, Netherlands), 2013-04, Vol.80 (1), p.1-4

2013

Volltextzugriff (PDF)

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers

British journal of cancer, 2011-08, Vol.105 (5), p.628-639

2011

Volltextzugriff (PDF)

Recent advances in radiotherapy

BMC medicine, 2010-04, Vol.8 (1), p.25-25, Article 25

2010

Volltextzugriff (PDF)

Developing a National Infrastructure for Proton Beam Therapy Trials

Clinical oncology (Royal College of Radiologists (Great Britain)), 2023-05, Vol.35 (5), p.279-282

2023

Volltextzugriff (PDF)

Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma

Annals of oncology, 2009-07, Vol.20 (7), p.1275-1279

2009

Volltextzugriff (PDF)

SP-0102: Redefining the dose distribution (i.e. dose painting with/without dose escalation/dose de-escalation)

Radiotherapy and oncology, 2013-03, Vol.106, p.S40-S40

Nutting, C

2013

Volltextzugriff (PDF)

Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects

British journal of cancer, 2005-02, Vol.92 (3), p.488-498

2005

Volltextzugriff (PDF)

SP-0608 IMRT FOR WHICH PATIENTS AND FOR WHAT BENEFIT?

Radiotherapy and oncology, 2012-05, Vol.103, p.S240-S240

Nutting, C

2012

Volltextzugriff (PDF)

SP-0001 Developing a national infrastructure for proton beam therapy trials

Radiotherapy and oncology, 2022-05, Vol.170, p.S1-S1

Nutting, C.

2022

Volltextzugriff (PDF)

Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers

British journal of radiology, 2012-05, Vol.85 (1013), p.487-494

2012

Volltextzugriff (PDF)

Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck

British journal of cancer, 2011-08, Vol.105 (5), p.618-627

2011

Volltextzugriff (PDF)

8 INVITED Modern Radiotherapy Techniques to Spare Normal Tissues

European journal of cancer (1990), 2011, Vol.47, p.S5-S5

Nutting, C

2011

Volltextzugriff (PDF)

Dysphagia-optimised Intensity-modulated Radiotherapy Techniques in Pharyngeal Cancers: Is Anyone Going to Swallow it?

Clinical oncology (Royal College of Radiologists (Great Britain)), 2017-07, Vol.29 (7), p.e110-e118

2017

Volltextzugriff (PDF)

Clinical Features of Radiation-induced Carotid Atherosclerosis

Clinical oncology (Royal College of Radiologists (Great Britain)), 2014-02, Vol.26 (2), p.94-102

2014

Volltextzugriff (PDF)

SIDE-EFFECTS OF HEAD AND NECK CANCER TREATMENT AND POTENTIAL STRATEGIES TO REDUCE THEM

Radiotherapy and oncology, 2011, Vol.98, p.S15-S15

Nutting, C

2011

Volltextzugriff (PDF)

Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers

Cancer treatment reviews, 2010-11, Vol.36 (7), p.566-575

2010

Volltextzugriff (PDF)

Low Ventricular Stiffness Is Associated With Suboptimal Outcomes in Patients With a Single Right Ventricle After the Fontan Operation: A Novel Phenotype

Journal of the American Heart Association, 2024-09, Vol.13 (17), p.e035601

2024

Volltextzugriff (PDF)

Evaluation of a multi-atlas CT synthesis approach for MRI-only radiotherapy treatment planning

Physica medica, 2017-03, Vol.35, p.7-17

2017

Volltextzugriff (PDF)

Advances in radiotherapy for head and neck cancer

Oral oncology, 2010-06, Vol.46 (6), p.439-441

2010

Volltextzugriff (PDF)

Diastolic Dysfunction With Preserved Ejection Fraction After the Fontan Procedure

Journal of the American Heart Association, 2022-01, Vol.11 (2), p.e024095-e024095

2022

Volltextzugriff (PDF)

Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer

British journal of cancer, 2006-03, Vol.94 (5), p.631-636

2006

Volltextzugriff (PDF)

1 – 25 von 983

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(744)
Mit Volltextzugriff
(873)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(312)
Life Sciences & Biomedicine
(281)
Humans
(261)
Oncology
(193)
Male
(140)
Female
(124)
Hematology, Oncology And Palliative Medicine
(107)
Middle Aged
(90)
Nuclear Medicine
(74)
Adult
(71)
Biological And Medical Sciences
(71)
Clinical & Internal Medicine
(71)
Aged
(63)
Medical Sciences
(63)
Radiology, Nuclear Medicine & Medical Imaging
(48)
Head And Neck Neoplasms - Radiotherapy
(47)
Radiology
(47)
General & Internal Medicine
(45)
Medicine, General & Internal
(44)
Tumors
(44)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Radiotherapy in head and neck cancer management: United Kingdom National Multidisciplinary Guidelines

Rapid advances in auto-segmentation of organs at risk and target volumes in head and neck cancer

SP-0533: Combined modality treatment: risk-adapted intensified strategies and quality of life

Head and neck cancer--Part 1: Epidemiology, presentation, and prevention

Transformation to “high grade” neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinoma

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers

Recent advances in radiotherapy

Developing a National Infrastructure for Proton Beam Therapy Trials

Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma

SP-0102: Redefining the dose distribution (i.e. dose painting with/without dose escalation/dose de-escalation)

Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects

SP-0608 IMRT FOR WHICH PATIENTS AND FOR WHAT BENEFIT?

SP-0001 Developing a national infrastructure for proton beam therapy trials

Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers

Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck

8 INVITED Modern Radiotherapy Techniques to Spare Normal Tissues

Dysphagia-optimised Intensity-modulated Radiotherapy Techniques in Pharyngeal Cancers: Is Anyone Going to Swallow it?

Clinical Features of Radiation-induced Carotid Atherosclerosis

SIDE-EFFECTS OF HEAD AND NECK CANCER TREATMENT AND POTENTIAL STRATEGIES TO REDUCE THEM

Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers

Low Ventricular Stiffness Is Associated With Suboptimal Outcomes in Patients With a Single Right Ventricle After the Fontan Operation: A Novel Phenotype

Evaluation of a multi-atlas CT synthesis approach for MRI-only radiotherapy treatment planning

Advances in radiotherapy for head and neck cancer

Diastolic Dysfunction With Preserved Ejection Fraction After the Fontan Procedure

Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer

Suchergebnisse filtern